ZINECARD

This brand name is authorized in Canada, United States

Active ingredients

The drug ZINECARD contains one active pharmaceutical ingredient (API):

1 Dexrazoxane UNII 5346058Q7S - DEXRAZOXANE HYDROCHLORIDE

Dexrazoxane has two major mechanisms of action, chelation of iron and inhibition of topoisomerase II. It is not known to what extent each of these mechanisms contributes to the preventive effect on tissue destruction following anthracycline extravasation. Read about Dexrazoxane

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZINECARD Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V03AF02	Dexrazoxane	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AF Detoxifying agents for antineoplastic treatment
Discover more medicines within V03AF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02153432
Country: US	FDA, National Drug Code	Identifier(s): 0013-8717